Choose your font:
 Arimo
 Merriweather
 Mukta Malar
 Open Sans Condensed
 Rokkitt
 Source Sans Pro
 Login


 English 
 Français 
 Português 

[Valid RSS] RSS

Database - Alliance francophone pour l'accouchement respecté (AFAR)

http://afar.info/id=1935
Created on : 30/03/2006
Modified on : 2/12/2007

Modify this record
Do not follow this link unless you know an editor’s password!

hard

Author(s) :

Goldberg AB, Wing DA.

Bibliographical entry (without author) :

Induction of labor: the misoprostol controversy. Review. {USA}. J Midwifery Womens Health. 2003 Jul-Aug;48(4):244-8.

Year of publication :

2003

Résumé (français) :

Abstract (English):

Misoprostol (Cytotec) is safe and effective for induction of labor, although it is not approved by the Food and Drug Administration (FDA) for use in pregnancy. In August 2000, the manufacturer of misoprostol warned against its use in pregnancy because of its abortifacient properties and cited reports of maternal and fetal deaths when misoprostol was used to induce labor, fueling the misoprostol controversy. More than 45 randomized trials including more than 5400 women have found vaginal misoprostol to be more effective than oxytocin or vaginal prostaglandin E2 at effecting vaginal delivery within 24 hours. Cesarean delivery rates with vaginal misoprostol are lower than with oxytocin alone, but similar to prostaglandin E2. There have been no significant differences in the frequency of serious adverse maternal or neonatal outcomes with low-dose misoprostol compared with oxytocin or prostaglandin E2; however, the relative risk of rare adverse outcomes with misoprostol is unknown. The data suggest that absolute risks are low when misoprostol is used appropriately. We recommend 25 mcg vaginally every 4 to 6 hours for carefully selected patients in closely monitored settings. Whether misoprostol will prove to be the most cost-effective agent for inducing labor in women with an unfavorable cervix remains to be determined.

Sumário (português):

URL :

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1286790

Comments :

Argument (français) :


Argument (English):

Argumento (português):

Keywords :

c-section/caesarean ; induction of labor ; duration of labour ; evidence-based medicine/midwifery ; misoprostol (Cytotec) ; oxytocin ; physiology ; maternal age ; risk of litigation ; law ; post-term pregnancy

Author of this record :

Cécile_Loup — 30/03/2006


DateDiscussion (only in English)Author
 
➡ Only identified users


 I have read the guidelines of discussions and I accept all terms (read guidelines)

New expert query ---  New simple query

Creating new record --- Importing records

User management --- Dump database

bar

This database is managed by Alliance francophone pour l'accouchement respecté (AFAR, http://afar.info)
affiliated with Collectif interassociatif autour de la naissance (CIANE, http://ciane.net).
It is fed by the voluntary contributions of persons interested in the sharing of scientific data.
If you agree with this project, you can support us in several ways:
(1) becoming a member of AFAR
(2) financially supporting AFAR
(3) contributing to this database if you have a minimum training in scientific documentation.
Sign in or create an account to follow changes or become an editor.
Contact afar.association(arobase)gmail.com for more information.

Valid CSS! Valid HTML!